UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 16, 2022 4:15 P.M.
Form:
S-3
CIK:
0001106838
Company Name:
Sonnet BioTherapeutics Holdings, Inc.
File Number:
333-267171